Free Account Opening + AMC Free Demat
Loading...

Metro Brands IPO vs Supriya Lifescience IPO

Comparision between Metro Brands IPO and Supriya Lifescience IPO.

IPO Details

Metro Brands IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Metro Brands IPO is up to ₹1,367.51 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Metro Brands IPO is ₹500.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.

  Metro Brands IPO Supriya Lifescience IPO
Face Value ₹5 per share ₹2 per share
Issue Price (Lower) ₹485.00 per share ₹265.00 per share
Issue Price (Upper) ₹500.00 per share ₹274.00 per share
Issue Price (Final) ₹500.00 per share ₹274.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 30 shares 54 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹295.00 Cr up to ₹200.00 Cr
OFS Issue Size 2,14,50,100 shares
OFS Issue Size (Amount) up to ₹1,072.51 Cr up to ₹500.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,367.51 Cr up to ₹700.00 Cr

IPO Timetable

Metro Brands IPO opens on Dec 10, 2021, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Metro Brands IPO and Supriya Lifescience IPO is Dec 14, 2021, and Dec 20, 2021, respectively.

  Metro Brands IPO Supriya Lifescience IPO
Anchor Bid Date
Issue Open Dec 10, 2021 Dec 16, 2021
Issue Close Dec 14, 2021 Dec 20, 2021
Basis Of Allotment (Tentative) Dec 17, 2021 Dec 23, 2021
Initiation of Refunds (Tentative) Dec 20, 2021 Dec 24, 2021
Credit of Share (Tentative) Dec 21, 2021 Dec 27, 2021
Listing date (Tentative) Dec 22, 2021 Dec 28, 2021
Anchor Lockin End date 1 Jan 16, 2022 Jan 22, 2022
Anchor Lockin End date 2 Mar 17, 2022 Mar 23, 2022

Financials

Metro Brands IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .

  Metro Brands IPO Supriya Lifescience IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 17,396.06 16,593.40 16,174.23 13,215.06
Total Revenue 4,892.68 8,785.38 13,110.68 12,368.95
Profit After Tax 430.74 646.19 1,605.75 1,527.31
Summary of financial Information (Restated Standalone)
Particulars For the year/period ended (₹ in Millions)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 5,041.02 4,458.24 3,364.01 2,530.52
Total Revenue 2,300.61 3,962.21 3,227.13 2,858.62
Profit After Tax 659.59 1,238.28 733.74 394.24
Promoter Shareholding (Pre-Issue) 84.02% 99.98%
Promoter Shareholding (Post-Issue) 74.27% 68.24%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Metro Brands IPO retail investors (RII) are offered 95,72,535 shares while in Supriya Lifescience IPO retail investors are offered 95,72,535 shares. Qualified institutional buyers (QIB) are offered 54,70,020 shares in Metro Brands IPO and 79,24,527 shares in Supriya Lifescience IPO.

  Metro Brands IPO Supriya Lifescience IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 54,70,020 shares 79,24,527 shares
NII 41,02,515 shares 39,62,263 shares
RII 95,72,535 shares 26,41,509 shares
Employee 0 shares 0 shares
Others
Total 1,91,45,070 shares 1,45,28,299 shares

Bids Received (Subscription)

Metro Brands IPO subscribed 3.64x in total, whereas Supriya Lifescience IPO subscribed 71.51x.

  Metro Brands IPO Supriya Lifescience IPO
QIB (times) 8.49x 31.83x
NII (times) 3.02x 161.22x
Big NII (times)
Small NII (times)
RII (times) 1.13x 56.01x
Employee (times)
Other (times)
Total (times) 3.64x 71.51x

Comments

Add a public comment...